Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Pfeilschifter

Showing results (231-240 of 320) with videos related to

Pageof 32
Sort By:
Experimental Cell Research|September 22, 2014
The cytoskeletal inhibitors latrunculin A and blebbistatin exert antitumorigenic properties in human hepatocellular carcinoma cells by interfering with intracellular HuR traffickingAnke Doller, Amel Badawi, Tobias Schmid, et al.
Journal of the American Society of Nephrology : JASN|July 7, 2009
Nitric oxide inhibits glomerular TGF-beta signaling via SMOC-1Ellen Dreieicher, Karl-Friedrich Beck, Sandra Lazaroski, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|May 20, 2021
Loss of sphingosine kinase 2 enhances Wilm's tumor suppressor gene 1 and nephrin expression in podocytes and protects from streptozotocin-induced podocytopathy and albuminuria in miceFaik Imeri, Bisera Stepanovska Tanturovska, Stephanie Schwalm, et al.
Plos One|September 19, 2015
Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with CirrhosisGeorgios Grammatikos, Nerea Ferreiròs, Oliver Waidmann, et al.
The Journal of Investigative Dermatology|January 19, 2005
Characterization and differentiation-dependent regulation of secreted phospholipases A in human keratinocytes and in healthy and psoriatic human skinUlrike Haas, Maurizio Podda, Martin Behne, et al.
Biochemical and Biophysical Research Communications|September 2, 2009
The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemiaBozena Czech, Waltraud Pfeilschifter, Niloufar Mazaheri-Omrani, et al.
Journal of Viral Hepatitis|December 4, 2022
The role of serum sphingolipids as potential biomarkers of non-response to direct acting antiviral therapy in chronic hepatitis C virus infectionAissa Miriam Röhrig, Katja Jakobi, Julia Dietz, et al.
International Journal of Molecular Sciences|May 19, 2018
Downregulation of the S1P Transporter Spinster Homology Protein 2 (Spns2) Exerts an Anti-Fibrotic and Anti-Inflammatory Effect in Human Renal Proximal Tubular Epithelial CellsOlivier Blanchard, Bisera Stepanovska, Manuel Starck, et al.
Therapeutic Advances in Neurological Disorders|May 19, 2018
Beta adrenoceptor blockade ameliorates impaired glucose tolerance and alterations of the cerebral ceramide metabolism in an experimental model of ischemic strokeSebastian Luger, Annette Schwebler, Rajkumar Vutukuri, et al.
Thrombosis and Haemostasis|November 15, 2007
Activated protein C downregulates p38 mitogen-activated protein kinase and improves clinical parameters in an in-vivo model of septic shockMarcel F Nold, Claudia A Nold-Petry, Doris Fischer, et al.
Pageof 32

Showing results (231-240 of 320) with videos related to

Sort By:
Pageof 32
Experimental Cell Research|September 22, 2014
The cytoskeletal inhibitors latrunculin A and blebbistatin exert antitumorigenic properties in human hepatocellular carcinoma cells by interfering with intracellular HuR traffickingAnke Doller, Amel Badawi, Tobias Schmid, et al.
Journal of the American Society of Nephrology : JASN|July 7, 2009
Nitric oxide inhibits glomerular TGF-beta signaling via SMOC-1Ellen Dreieicher, Karl-Friedrich Beck, Sandra Lazaroski, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|May 20, 2021
Loss of sphingosine kinase 2 enhances Wilm's tumor suppressor gene 1 and nephrin expression in podocytes and protects from streptozotocin-induced podocytopathy and albuminuria in miceFaik Imeri, Bisera Stepanovska Tanturovska, Stephanie Schwalm, et al.
Plos One|September 19, 2015
Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with CirrhosisGeorgios Grammatikos, Nerea Ferreiròs, Oliver Waidmann, et al.
The Journal of Investigative Dermatology|January 19, 2005
Characterization and differentiation-dependent regulation of secreted phospholipases A in human keratinocytes and in healthy and psoriatic human skinUlrike Haas, Maurizio Podda, Martin Behne, et al.
Biochemical and Biophysical Research Communications|September 2, 2009
The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemiaBozena Czech, Waltraud Pfeilschifter, Niloufar Mazaheri-Omrani, et al.
Journal of Viral Hepatitis|December 4, 2022
The role of serum sphingolipids as potential biomarkers of non-response to direct acting antiviral therapy in chronic hepatitis C virus infectionAissa Miriam Röhrig, Katja Jakobi, Julia Dietz, et al.
International Journal of Molecular Sciences|May 19, 2018
Downregulation of the S1P Transporter Spinster Homology Protein 2 (Spns2) Exerts an Anti-Fibrotic and Anti-Inflammatory Effect in Human Renal Proximal Tubular Epithelial CellsOlivier Blanchard, Bisera Stepanovska, Manuel Starck, et al.
Therapeutic Advances in Neurological Disorders|May 19, 2018
Beta adrenoceptor blockade ameliorates impaired glucose tolerance and alterations of the cerebral ceramide metabolism in an experimental model of ischemic strokeSebastian Luger, Annette Schwebler, Rajkumar Vutukuri, et al.
Thrombosis and Haemostasis|November 15, 2007
Activated protein C downregulates p38 mitogen-activated protein kinase and improves clinical parameters in an in-vivo model of septic shockMarcel F Nold, Claudia A Nold-Petry, Doris Fischer, et al.
Pageof 32